750 likes | 917 Views
THE BREAST. Dr.JAMIL SAWAKED. ANATOMY. TERES MAJOR. LATISSIMUS DORSI. SERRATUS ANTER. FAT. LOBE. MAJOR LACT.DUCT IS THE SITE OF DUCTAL CA . RIBS &intercost.m. AMPULLA. PECTORALIS MAJOR. 20 MAJOR LACT.ORIFICES. LACTOCYTE. THEIR CONTRACTION CAUSES SKIN DIMPLING.
E N D
THE BREAST Dr.JAMIL SAWAKED
ANATOMY TERES MAJOR LATISSIMUSDORSI SERRATUS ANTER
FAT LOBE MAJORLACT.DUCT IS THE SITE OF DUCTAL CA. RIBS &intercost.m AMPULLA PECTORALIS MAJOR 20 MAJOR LACT.ORIFICES LACTOCYTE
THEIR CONTRACTION CAUSES SKIN DIMPLING PEAU d`ORANGE IS DUE TO OEDEMA OF SKIN LYMPHATIC
DUCT SYSTEM MAJORDUCT
[MINOR] OR [ TERMINAL] MINOR DUCT ISTHE SITEOF LOBULARCARCINOMA
APICAL CENTRAL SUPERIORTHORACIC V. LATERAL SUBSCAP.V INTERNALMAMMARY L.N. RPOSTERIO PECTORAL LAT.THOR.V SENTINELL.N LONG THORACIC N 85% OF THEBREAST DRAININTOTHE AXILLA
IF IT IS FILLED WITH MILK IT IS GALACTOCELE
MASTITIS;PLUGGED DUCT OR CRACKED NIPPLE,[STAPHYLLOCOCCI] ABSCESS
TYPES OF MASTITIS • MASTITIS NEONATORUM • MASTITIS OF PUBERTY • LACTATING MASTITIS • SPECIFIC MASTITIS; • 1-T.B MASTITIS • 2-SYPHILITIC MASTITIS • 3-ACTINMYCOSIS
BENIGN BREAST DISEASE • FIBROADENOMA • FIBROCYSTIC DIS • DUCTECTASIA • BENIGN CYSTS • LIPOMA:VERY RARE [DANGEROUS TO DIAGNOSE LIPOMA]
FIBROADENOMA BREAST MOUSE SMALL ONES COULD BE LEFT ALONE
CYSTOSARCOMA PHYLLOIDES • THOUGHT TO BE MALIGNANT [NOTICE THE NAME] BUT IT IS NOT. MAY REACH HUGE SIZE &ULCERATE HOWEVER THERE ARE WORRYING MITOTIC FIGURES SOMETIMES DENOTING MALIGNANT POTENTIAL
WHEN A BENIGN BREASTDISEASE BECOMES WORRYING? • WHEN A PATHOLOGY SPECIMEN SHOWS ATYPICAL HYPERPLASIA • FLORID HYREPLASIA CARRIES AMILD RISK • NB;METAPLASIA AND MILD HYPERPLASIA CARRY NO RISK
CYSTS • ANDI • LYMPHATIC CYSTS • HYDATID CYST • GALACTOCELE • SEROCYSTIC DISEASE OF BRODIE • INTRACYSTIC PAPILLIFEROUS CA • COLLOID DEGENERATION OF CA. • PAPILLARY CYSTADENOMA
CYSTS • BENIGN • MALIGNANT MANAGEMENT OF A CYST ASPIRATE & OPERATE OR CORE BIOPSY IF; 1-BLOODY ASPIRATE 2-DID NOT DISAPPEAR COMPLETELY AFTER ASPIRATION 3-RECURES IN 6 WEEKS
NIPPLE DISCHARGE • I=NONBLOODY; 1-FIBROCYSTIC DISEASE 2-DUCTECTASIA • II=BLOODY; 1-DUCTECTASIA; COMMON 2-DUCT PAPILLOMA; MOST COMMON 3-DUCT CARCINOMA;VERYRARE
MICRODOCHECTOMY FOR BLEEDING NIPPLE BLEEDING SEGMENT IS REMOVED AND SUBMITTED TO HISTOPATHOLOGY PROBE DETERMINE FIRST WHICH ORIFICE OR SEGMENT IS BLEEDING BY PRESSING AROUND THE AREOLA
BREAST CANCER • DUCTAL CARCINOMA [90%] • LOBULAR CARCINOMA[<10%] • PAGET`S DISEASE • INTRACYSTIC PAPILLIFEROUS CA • SARCOMA
What Are the Risk Factors for Breast Cancer? • 1-Age; INCREASING AGE • 2-Race;WHITE++.RARE IN JAPAN, • 3-Individual or family history of breast cancer • 4-A history of ovarian cancer • 5-A genetic predisposition (mutations to the BRCA1 or BRCA2 genes cause 2% to 3% of all breast cancers) • 6-Estrogen exposure;MENARHE,MENOPAUSE • 7-Atypical hyperplasia of the breast • 8-Lobular carcinoma in situ (LCIS) • 9-Lifestyle factors (obesity, lack of exercise, alcohol use) • 10-Radiation • 1-Age; INCREASING AGE • 25:1/20,000.45:1/100.50:1/50.55:1/33.60:1/24. 80:1/10. • 2-Race;WHITE++.RARE IN JAPAN, • 3-Individual or family history of breast cancer • 4-A history of ovarian cancer • 5-A genetic predisposition (mutations to the BRCA1 or BRCA2 genes cause 2% to 3% of all breast cancers) • 6-Estrogen exposure;MENARHE,MENOPAUSE • 7-Atypical hyperplasia of the breast • 8-Lobular carcinoma in situ (LCIS) • 9-Lifestyle factors (obesity, lack of exercise, alcohol use ) • 10-Radiation
About 15%?[3-15]of breast cancers are inherited Approximately 80% of hereditary breast cancer is caused by mutations in the BRCA1 or BRCA2 genes.P53 has a role too Women who inherit a BRCA mutation have a 50% to 85% chance of developing breast cancer in their lifetime Women with especially strong family history may consider preventive surgery to remove breast tissue and/or chemoprevention Several other genetic syndromes can increase breast cancer risk
SITES RT. LT. LT.BREAST 60 60 12% 60% 6 6 12% 10% 6%
MODE OF SPREAD OF DUCTAL CARCINOMA • LOCAL • LYMPHATIC • BLOOD; BONE SOFT TISSUE 1-LUMBER V. 1-LIVER 2-FEMUR 2-LUNG 3-THORAC V. 3-BRAIN 4-RIBS 4-KIDNEY 5-SKULL 5-ADRENALS
DIAGNOSIS TRIPLE ASSESSMENT • 1-CLINICAL: A-AGE . B-EXAMINATION • 2-IMAGING : A-US . B-MAMMOGRAM • 3-PATHOLOGY: A-FNA. B-CORECUT
FNA & CORECUT • FNA [CYTOLOGY EXAMINATION] HAS 5% FALSE –VE MOSTLY DUE TO SAMPLING ERROR • CORECUT [TRUCUT] IS A TISSUE HISTOPATHOLOGY THAT IS MORE ACCURATE AND TELLS YOU ABOUT THE GRADE & INVASIVENESS; IN-SITU OR INVASIVE
MAMMOGRAM MALIGNANT • 1-CALCIFICATION; CLUSTER[5-6] OF BRANCHED FINE MICROCALCIFICATION • 2-ARCHITECTURAL CHANGES; SPIKY DENSE IRREGULAR MASS BENIGN WELL DEFINED ROUNDED MASS WITH HALO SIGN; CYST,FIBROADENOMA
MAMMOGRAM CONVENTIONAL & DIGITAL • IT IS NON USED FOR YOUNGER WOMEN BECAUSE THEIR DENSE BREAST TISSUE GIVES FALSE POSITIVE RESULTS • BUT IT IS GOOD FOR THE SOFT BREASTS BECAUSE THE GLANDULAR TISSUE IS SEPERATED BY FAT PLANES
MRI IS THE MOST SENSITIVE 1- CAN PICK UP CARCINOMA IN-SITU 2- DIFFERENTIATES BETWEEN LOCAL RECURRENCE AND FIBROSIS
MRI • NO RADIATION BUT MAGNETIC FIELD • 1-CAN VISUALIZE A PALPAPABLE MASS WHICH IS NOT SEEn ON U/S OR MAMMOGRAM • 2-CAN BE USEFUL IN YOUNG WOMEN • 3-CAN LOCATE BREAST CANCER WITH AXILLARY L.N. METS BUT BREAST FREE ON US OR MAMMOGRAM • 4-CAN DETECT MULTICENTRIC LESION • 5-CAN DIFFERENTIATE BETWEEN RECURRENCE AND FIBROUS TISSUE • 6-CAN DETECT SILICON LEAK • DISADVANTAGES • 1-CANNOT DETECT CALCIFICATIONS • UBOS:UNIDETIFIED BRIGHT OBJECTS • DISLODGE CERTAIN METALS;RACEMAKER • EXPENSIVE
MULTIPLE LOCAL RECURRENCE CANCER EN-CUIRASSE درع المحارب
LYMPHOEDEMA COMBINATION OF SURGERY &RADIOTHERAPY ON THE AXILLA CANCAUSE THIS
DIFF.DIAGNOSIS OFMASTITIS & MASTITIS CARCINOMATOSA MASTITIS CARCINOMATOSA [INFLAMMATORY CARCINOMA] • IS THE MOST MALIGNANT OF ALL BR. CA. • MASTECTOMY IS RARELY INDICATED BECAUSE IT IS LATE • NO CONSTITUTIONAL SYMPTOMS • NO FEVER • NO LEUCOCYTOSIS • SKIN OEDEMA > 1/3 OF THE BREAST • IN BOTH THE BREAST IS WARM,TENDER • BOTH OCCUR IN CHILD BEARING PERIOD • DIFFICULT TO DISTINGUISH SOMETIMES EXCEPT BY CORECUT BIOPSY. • US & MAMMOGRAM ARE USELESS BECAUSE THERE IS NO MASS
DIFF.DIAGNOSIS OF PAGET`S DISEASE &ECZEMA OF THE NIPPLE PAGET`S DISEASE • THERE IS AN UNDERLYING BREAST CANCER • UNILATERAL • NIPPLE DESTRUCTION • BOUNDRIES OF THE LESION IS WELL DEMARKATED • DOES NOT RESPOND TO STEROID LOCAL THERAPY